#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital generalised lipodystrophy Anal cancer recurrent Pemphigus Myeloproliferative neoplasm Bronchiolitis Kearns-Sayre syndrome Nephropathy Antithrombin III deficiency Noonan syndrome Congenital nephrogenic diabetes insipidus Alagille syndrome Myotonic dystrophy ABO haemolytic disease of newborn Brain stem glioma Vaginal cancer More trials…

    Learn about Rare Diseases

    Combined immunodeficiency Haemophagocytic lymphohistiocytosis – Treatment Ocular melanoma – Trials in Disease Burkitt’s lymphoma Short-bowel syndrome – Trials in Disease Leiomyosarcoma – Diagnostics Lymphangioma – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Basic Information Lysosomal storage disorder – Treatment Osteosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vortioxetine Hydrobromide Dolutegravir Zongertinib Metoprolol Succinate Sodium Lactate Eftilagimod Alfa Fentanyl Belantamab Mafodotin Lucerastat Crinecerfont PIPOTIAZINE AZD0120 Terlipressin Acetate L-Histidine Ebastine Hyoscine Butylbromide Nemvaleukin Alfa Somapacitan Aliskiren Dextromethadone Hydrochloride More therapies…

    Learn about Your Condition

    Electrocorticogram Metabolic surgery Anaemia Endometrial cancer stage III Ureteric cancer Uterine cancer Vesicoureteric reflux Hand fracture Cold urticaria Bronchiolitis Hypotension Right ventricular dysfunction Testis cancer Corneal graft failure Hypoxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune System Phenomena

  • Study on Pneumococcal Vaccine Response in Healthy Volunteers Using Pneumococcal Polysaccharide Conjugate Vaccine and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    The Netherlands

  • Study on the Effects of the Dengue Vaccine Qdenga on Antibody Levels in Swedish Travelers

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dengue fever
    Sweden

  • Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Study on Prednisolone for Treating Acute Interstitial Nephritis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tubulointerstitial nephritis
    Investigated Drugs:
    • Prednisolone
    Denmark

  • Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Mdna11
    • Pembrolizumab
    Ireland Poland Portugal Spain
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!